-
1121por Barakat, Ashraf Abd El-Khalik, Nasr, Fatma Mohammad, Metwaly, Amna Ahmed, Morsy, Sherif, Eldamarawy, Mervat“…BACKGROUND: Chronic Hepatitis C virus (HCV) infection and liver cirrhosis may be associated with atherosclerosis and coronary artery disease (CAD). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1122
-
1123por Gheorghe, Dorin Nicolae, Foia, Liliana, Toma, Vasilica, Surdu, Amelia, Herascu, Elena, Popescu, Dora Maria, Surlin, Petra, Vere, Cristin Constantin, Rogoveanu, Ion“…Hepatitis C virus (HCV) infections could have an important impact on the oral health status of patients, favoring conditions such as periodontal disease and oral cancer. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1124por Zahr, Natalie M.“…As successfully treated individuals with Human Immunodeficiency Virus (HIV)-infected age, cognitive and health challenges of normal aging ensue, burdened by HIV, treatment side effects, and high prevalence comorbidities, notably, Alcohol Use Disorders (AUD) and Hepatitis C virus (HCV) infection. In 2013, people over 55 years old accounted for 26% of the estimated number of people living with HIV (~1.2 million). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1125por Hill, Andrew, Tahat, Loai, Mohammed, Mohammed Khalil, Tayyem, Rabab Fayez, Khwairakpam, Giten, Nath, Sanjay, Freeman, James, Benbitour, Ismahane, Helmy, Sherine“…Mass production of low-cost, generic direct-acting antivirals (DAAs) will be required to achieve targets of eliminating hepatitis C (HCV) by 2030. The pharmaceutical companies Gilead and Bristol-Myers Squibb have granted voluntary licences (VLs) to generic companies to mass produce the DAAs sofosbuvir and daclatasvir at low cost. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1126por Hijikata, Makoto, Kato, Nobuyuki, Mori, Shigehisa, Ootsuyama, Yuko, Nakagawa, Masanori, Sugimura, Takashi, Ohkoshi, Showgo, Kojima, Hideo, Meguro, Takashi, Taki, Masashi, Takayama, Shigenobu, Yamada, Kaneo, Shimotohno, Kunitada“…Recently we found that hepatitis C virus (HCV) could be classified into at least two types, HCV‐US and HCV‐J, depending on the nucleotide sequence. …”
Publicado 1990
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1127por Kato, Nobuyuki, Ikeda, Masanori, Mizutani, Tetsuya, Sugiyama, Kazuo, Noguchi, Masayuki, Hirohashi, Setsuo, Shimotohno, Kunitada“…We established a replication system for hepatitis C virus (HCV) using the PH5CH non‐neoplastic human hepatocyte line that had been immortalized with simian virus 40 large T antigen. …”
Publicado 1996
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1128por Sugiyama, Kazuo, Kato, Nobuyuki, Ikeda, Masanori, Mizutani, Tetsuya, Shimotohno, Kunitada, Kato, Tomoyasu, Sugiyama, Yuko, Hasumi, Katsuhiko“…Based on epidemiological evidence, hepatitis C virus (HCV) is thought to be involved in the etiology of not only hepatocellular carcinoma, but also lymphoproliferative diseases. …”
Publicado 1997
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1129por Vopálenský, Václav, Khawaja, Anas, Rožnovský, Luděk, Mrázek, Jakub, Mašek, Tomáš, Pospíšek, Martin“…Hepatitis C virus (HCV) is a single-stranded positive-sense RNA virus from the genus Hepacivirus. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1130“…To characterize hepatitis C virus (HCV) epidemiology in Pakistan and estimate the pooled mean HCV antibody prevalence in different risk populations, we systematically reviewed all available records of HCV incidence and/or prevalence from 1989 to 2016, as informed by the Cochrane Collaboration Handbook. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1131por Batsaikhan, Batbold, Huang, Ching-I, Yeh, Ming-Lun, Huang, Chung-Feng, Hou, Nei-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Yu, Ming-Lung, Chuang, Wan-Long, Lee, Jin-Ching, Dai, Chia-Yen“…BACKGROUND: Low lipid profile is associated with hepatitis C virus (HCV) infection. Chronic HCV infection is the main cause of liver injury and serum lipid levels during antiviral treatment. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1132“…Hepatitis C virus (HCV) is a major global health concern, and though therapeutic options have improved, no vaccine is available despite decades of research. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1133por Zhu, Li, Li, Hanbin, Chan, Phyllis, Eley, Timothy, Gandhi, Yash, Bifano, Marc, Osawa, Mayu, Ueno, Takayo, Hughes, Eric, AbuTarif, Malaz, Bertz, Richard, Garimella, Tushar“…INTRODUCTION: Asunaprevir (ASV) is a potent, pangenotypic, twice-daily hepatitis C virus (HCV) NS3 inhibitor indicated for the treatment of chronic HCV infection. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1134por Delile, Jean-Michel, de Ledinghen, Victor, Jauffret-Roustide, Marie, Roux, Perrine, Reiller, Brigitte, Foucher, Juliette, Dhumeaux, Daniel“…After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an expert report presented recommendations, which focused on vulnerable groups including people who inject drugs (PWID). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1135“…OBJECTIVE: Evaluating the auditory function in patients with chronic hepatitis C treated with sofosbuvir and ribavirin. METHODS: This study involved 80 patients with chronic hepatitis C who agreed to receive sofosbuvir and ribavirin. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1136“…The high genetic variability of hepatitis C virus, together with the high level of glycosylation on the viral envelope proteins shielding potential neutralizing epitopes, pose a difficult challenge for vaccine development. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1137por Husic-Selimovic, Azra, Sofic, Amela, Jahic, Elma, Prohic, Dzanela, Merhemic, Zulejha“…Screening of blood products for HCV has eradicated transfusion-transmitted hepatitis C in most countries since 1992–in Bosnia and Herzegovina, however, since 1995, due to the war. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1138“…Hepatitis C virus (HCV) infection remains an important global health problem with chronic infection affecting approximately 11 million children worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1139por Uddin, Syed Mohammad Mazhar, Haq, Aatera, Haq, Zara, Yaqoob, Uzair, Shah, Haider, Kazmi, Syed Faheem Ali“…Additional investigations revealed he was positive for Plasmodium falciparum, HIV, hepatitis B, and hepatitis C. In addition, a test of his cerebrospinal fluid revealed evidence of cerebral malaria. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1140por Mansberg, Kairi, Kull, Karin, Salupere, Riina, Prükk, Tiina, Margus, Benno, Kariis, Toomas, Remmel, Triin, Suurmaa, Külliki, Ott, Kristi, Jaago, Krista, Šmidt, Jelena“…Background and objective: The hepatitis C virus (HCV)-infected patients serve as a reservoir for transmission of the disease to others and are at risk of developing chronic hepatitis C, cirrhosis, and hepatocellular carcinoma. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto